NCT04590235 2026-01-30A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)AstraZenecaPhase 1 Active not recruiting32 enrolled